Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial of a Strategic Disclosure Intervention for Suicide Attempt Survivors

NCT05018897 is registered in ClinicalTrials.gov with Illinois Institute of Technology as lead sponsor.

NCT NCT05018897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05018897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial of a Strategic Disclosure Intervention for Suicide Attempt Survivors
Lead sponsor
Illinois Institute of Technology
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2021
Completion date
August 31, 2022
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mood disorders, suicide, attempted